BRIEF published on 12/20/2024 at 13:14, 11 months 15 days ago Turkiye Garanti Bankasi Finalizes Acquisition of Galataport Shares Investor Relations Share Transfer Garanti Bank Galataport Acquisition Turkish Market
BRIEF published on 12/20/2024 at 13:10, 11 months 15 days ago Turkiye Garanti Bankasi Sells Non-Performing Loan Portfolio Debt Management Financial Strategy Turkiye Garanti Bankasi Non-Performing Loans Portfolio Sale
PRESS RELEASE published on 12/20/2024 at 13:09, 11 months 15 days ago Turkiye Garanti Bankasi A.S.: Regarding the Acquisition of Galataport Shares Turkiye Garanti Bankasi A.S. completes the acquisition of 12.28% shares of Galataport İstanbul Liman İşletmeciliği ve Yatırımları A.Ş. as per Material Event Disclosure Acquisition Turkiye Garanti Bankasi A.S. Share Transfer Investment Community Galataport Shares
PRESS RELEASE published on 12/20/2024 at 13:05, 11 months 15 days ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio Turkiye Garanti Bankasi A.S. sells non-performing loans portfolio to Gelecek, Ortak, Birikim, Dünya, and Sümer Varlık Yönetim A.S. for a total consideration of TL 701.5 million Investor Relations Turkiye Garanti Bankasi A.S. Non-Performing Loans Portfolio Sale Gelecek Varlik Yonetim A.S.
BRIEF published on 12/19/2024 at 15:10, 11 months 16 days ago Turkiye Garanti Bankasi A.S. Secures CMB Approval for Bond Issuance International Markets Bond Issuance Turkiye Garanti Bankasi Capital Markets Board GMTN Program
BRIEF published on 12/19/2024 at 15:06, 11 months 16 days ago Turkiye Garanti Bankasi A.S. Issues Capital Markets Instrument Note Investment Capital Markets Turkiye Garanti Bankasi Regulatory Standards Instrument Note
PRESS RELEASE published on 12/19/2024 at 15:05, 11 months 16 days ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets Turkiye Garanti Bankasi A.S. receives CMB approval for bond issuance in foreign markets under GMTN program. Issuance in GBP with maturity on 12.01.2026 Bond Issuance Turkiye Garanti Bankasi Foreign Markets CMB Approval GMTN Program
PRESS RELEASE published on 12/19/2024 at 15:01, 11 months 16 days ago Turkiye Garanti Bankasi A.S.: Prospectus – Capital Markets Instrument Note Turkiye Garanti Bankasi A.S. released a Prospectus for Capital Markets Instrument Note, approved by the Capital Markets Board. Contact their Investor Relations for more info Investor Relations Capital Markets Prospectus Turkiye Garanti Bankasi Board Communiqué
BRIEF published on 12/19/2024 at 15:00, 11 months 16 days ago Garanti BBVA Issues New Intermediary Institution Warrants Investor Relations Capital Markets Warrants Issuance Garanti BBVA Prospectus Summary
PRESS RELEASE published on 12/19/2024 at 14:55, 11 months 16 days ago Turkiye Garanti Bankasi A.S.: Prospectus – Summary Garanti Bank Intermediary Institution Warrants prospectus summary approved by Capital Markets Board. Turkish version prevails in case of contradiction Prospectus Capital Markets Board Garanti Bank Intermediary Institution Warrants Turkish Version
Published on 12/05/2025 at 02:35, 4 hours 32 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 7 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 2 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 7 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 37 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 16 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 42 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 52 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 56 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 7 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 22 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 23 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
